Motif Bio plc (MTFB) (MTFB)

[Timing101]

Watch this ...
--
First the Military .. then into the Public Medical applications
--
Motif Bio Shares Jump After Signing U.S. Army-Funded Project
3:50 AM ET 10/24/19 | Dow Jones


By Sabela Ojea

Shares in Motif Bio PLC (MTFB.LN) rose 27% on Thursday after the company said that it has signed a U.S. Army-funded research project to evaluate Iclaprim, which would be used to prevent and treat wound infections on the battlefield.

The clinical-stage biopharmaceutical company said it has signed the contract with the Walter Reed Army Institute of Research through a grant from the U.S. Department of Defense.

The London-listed company added aerosol technology allows delivery of antibiotics painlessly and rapidly into skin and soft tissue with low-pressure and focused delivery.

"When a wound becomes infected, it is critical to provide safe and effective treatment as fast as possible," Chief Medical Officer David Huang said.

Shares at 0745 GMT were up 0.17 pence at 0.80 pence.

Write to Sabela Ojea at [e-mail]; @sabelaojeaguix

> Dow Jones Newswires